Brussels, 31/05/2007 (Agence Europe) - On Thursday 31 May, German Health Minister Ulla Schmidt welcomed the approval of a new regulation putting in place centralised marketing authorisation, through the European Medicines Agency in London, of new therapies developed from cell and tissue engineering as one of the major successes of the six-month German presidency. The Council of Ministers had just confirmed its second political agreement on the compromise text, which the Parliament had...